Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

B30X vs BS30


B30XInvesco BulletShares 2030 USD Corporate Bond UCITS ETF GBP Hdg Acc
IE000ELHT1P5 · Bonds · Corporate USD · Fixed maturity (iBonds) · Europe
BS30Invesco BulletShares 2030 USD Corporate Bond UCITS ETF Dist
IE000GB2EQ90 · Bonds · Corporate USD · Fixed maturity (iBonds) · North America
Open the interactive comparison on rebalix.com →

Comparison window: 8 Jul 202514 Aug 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 5 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixB30X vs BS30 · report of 5 September 2026

The funds at a glance

From official issuer documents and the ESMA register
B30XIE000ELHT1P5Invesco BulletShares 2030 USD Corporate Bond UCITS ETF GBP Hdg AccBonds · Corporate USD · Fixed maturity (iBonds) · Europe
Declared index
Bloomberg 2030 Maturity USD Corporate Bond Screened Index
TER
0.12%
Transaction (KID)
0.04%
Fund size
28 mln EUR
Launch
8 Jul 2025
Currency
GBP
Replication
Physical
Hedging
Yes — in GBP
Holdings
595
Duration
3.44 yrs
Distributions 12m
acc.
Effective 🇮🇹 rate
26.00%
BS30IE000GB2EQ90Invesco BulletShares 2030 USD Corporate Bond UCITS ETF DistBonds · Corporate USD · Fixed maturity (iBonds) · North America
Declared index
Bloomberg 2030 Maturity USD Corporate Bond Screened Index
TER
0.10%
Transaction (KID)
0.01%
Fund size
38 mln EUR
Launch
21 May 2024
Currency
USD
Replication
Physical
Hedging
No
Holdings
595
Duration
3.44 yrs
Distributions 12m
0.2358 USD
Effective 🇮🇹 rate
26.00%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
B30Xn/d
hedged class: the published index is unhedged, the gap would measure the exchange rate
BS30n/d
2025
−0.06%
Rebalix · B30X vs BS30section 1 of 4
RebalixB30X vs BS30 · report of 5 September 2026
B30XInvesco BulletShares 2030 USD Corporate Bond UCITS ETF GBP Hdg Acc · IE000ELHT1P5 · Bonds · Corporate USD · Fixed maturity (iBonds) · Europe
BS30Invesco BulletShares 2030 USD Corporate Bond UCITS ETF Dist · IE000GB2EQ90 · Bonds · Corporate USD · Fixed maturity (iBonds) · North America

Performance over the period, in euro

From 8 Jul 2025 to 14 Aug 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10010898105106
In today’s purchasing power (net of Italy inflation)
10010898102103
B30XBS30
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-2%-4%-6%-8%-10%B30XBS302026trough B30X: −2.5% · 14 Nov 2025trough BS30: −4.6% · 28 Jan 2026
Filled area: B30X; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
B30X−2.5%14 Nov 202546 days70 days · back to break-even on 30 Dec 2025
BS30−4.6%28 Jan 2026not yet378 days (ongoing)
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-2%-4%-6%-8%-10%B30XBS302026trough B30X: −5.0% · 15 May 2026trough BS30: −7.8% · 07 May 2026
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · B30X vs BS30section 2 of 4
RebalixB30X vs BS30 · report of 5 September 2026
B30XInvesco BulletShares 2030 USD Corporate Bond UCITS ETF GBP Hdg Acc · IE000ELHT1P5 · Bonds · Corporate USD · Fixed maturity (iBonds) · Europe
BS30Invesco BulletShares 2030 USD Corporate Bond UCITS ETF Dist · IE000GB2EQ90 · Bonds · Corporate USD · Fixed maturity (iBonds) · North America

Geographic composition

% of portfolio, from full declared holdings
B30XBS30

Sector composition

GICS sectors, same sources and dates
B30XBS30

Portfolio overlap

595 common holdings · ticker match on full official portfolios
25%50%75%100%Weight of common holdings in B30X100.0%Weight of common holdings in BS30100.0%Truly shared part (duplicated investment)100.0%
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 595 common holdings this gives 100.0%: buying both funds, roughly this share of your money buys the same stocks twice. Matching uses the ISIN of each security, as published by both issuers in their baskets.
Rebalix · B30X vs BS30section 3 of 4
RebalixB30X vs BS30 · report of 5 September 2026

Full comparison table

"—" = not published by the source, never estimated
B30XInvesco BulletShares 2030 USD Corporate Bond UCITS ETF GBP Hdg Acc · IE000ELHT1P5 · Bonds · Corporate USD · Fixed maturity (iBonds) · Europe
BS30Invesco BulletShares 2030 USD Corporate Bond UCITS ETF Dist · IE000GB2EQ90 · Bonds · Corporate USD · Fixed maturity (iBonds) · North America
MetricB30XBS30Note
Identity
CategoryBonds · Corporate USD · Fixed maturity (iBonds) · EuropeBonds · Corporate USD · Fixed maturity (iBonds) · North AmericaRebalix engine classification
ReplicationPhysicalPhysicalas declared by the issuer
Currency hedgingYes — hedged to GBPNosource: class name, factsheet
Income policyaccumulatingdistributing
Costs
TER0.12%0.10%from the KID
Transaction costs (KID)0.04%0.01%internal
All-in cost0.16%0.11%TER + transaction
Tracking difference (3a)vs its OWN index
Performance in euro (ECB rates)
1 year+3.5%+2.4%
3 years
5 years
10 years— = series younger than the window
Risk · last 3 years
Volatility (ann.)
Max drawdown
Sharperisk-free = ECB MRO avg
Sortinolike Sharpe, downside only
Fixed income
Duration3.44 yrs (eff.)3.44 yrs (eff.)B30X: factsheet 31 Jul 2026 · BS30: factsheet 31 Jul 2026
Duration bandmedium (3–7 years)medium (3–7 years)short ≤3 · medium 3–7 · long >7 yrs
Investment-grade share99.6%99.6%BBB−/Baa3 and above
Heaviest rating bucketBBB (52.7%)BBB (52.7%)
Most represented maturity3 to 5 years (99.6%)3 to 5 years (99.6%)
Distributions (fund currency)
Frequencyaccumulating classquarterly
Distributions, last 12 monthsaccumulating class0.2358 USDper share
Distribution yieldaccumulating class4.70%12 months / NAV
Last ex-dateaccumulating class10 Sept 2026 · 0.0584 USD
Italian taxation
Effective capital-gains rate26.00%26.00%white list, current half-year
Documents & exchanges
Listing venues9ESMA register
Borsa Italiana tickerBS30
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~102 euro B30X · ~70 euro BS30. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · B30X vs BS30section 4 of 4